NCT07027423
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07027423
Title BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
UHN- Princess Margaret Cancer Center Toronto Ontario M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field